Efficacy and side effects of cisplatin- and carboplatin-based doublet chemotherapeutic regimens versus non-platinum-based doublet chemotherapeutic regimens as first line treatment of metastatic non-small cell lung carcinoma: A systematic review of randomized controlled trials-Reference-Cited by-同舟云学术

Efficacy and side effects of cisplatin- and carboplatin-based doublet chemotherapeutic regimens versus non-platinum-based doublet chemotherapeutic regimens as first line treatment of metastatic non-small cell lung carcinoma: A systematic review of randomized controlled trials

Published:2008-01 Issue:1 Volume:59 Page:1-11
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Rajeswaran Anand,Trojan Andreas,Burnand Bernard,Giannelli Massimo

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference35 articles.

1. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. Non-Small Cell Lung Cancer Collaborative Group;BMJ,1995

2. American society of clinical oncology treatment of unresectable non-small cell lung cancer guideline: update 2003;Pfister;J Clin Oncol,2004

3. Platinum-based versus non-platinum-based chemotherapy in advanced non-small cell lung cancer: a meta-analysis of the published literature;D’Addario;J Clin Oncol,2005

4. Should chemotherapy combinations for advanced non-small cell lung cancer be platinum-based? A meta-analysis of phase III randomized trials;Pujol;Lung Cancer,2006

5. Randomized, multinational, phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small cell lung cancer: the TAX 326 study group;Fossella;J Clin Oncol,2003

Cited by 193 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Análise do perfil de devoluções de quimioterapias endovenosas em um hospital filantrópico de Salvador-BA;Vigilância Sanitária em Debate;2024-07-15

2. Synthesis, characterisation and in vitro anticancer activity of conjugated protease inhibitor–silver nanoparticles (AgNPs–PI) against human breast MCF-7 and prostate PC-3 cancer cell lines;Bioprocess and Biosystems Engineering;2024-05-06

3. Neoadjuvant docetaxel plus cisplatin versus docetaxel plus doxorubicin and cyclophosphamide in early-stage triple-negative breast cancer (HELEN-001): results from a multicenter, randomized controlled, open-label phase II trial;2024-04-11

4. Development, optimization and characterization of cisplatin loaded cubosomes for human lung carcinoma;Drug Development and Industrial Pharmacy;2024-03-20

5. Platinum-based targeted chemotherapies and reversal of cisplatin resistance in non-small cell lung cancer (NSCLC);Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis;2024-01